Literature DB >> 4984234

Immunoglobulin M: pentameric Fcmu fragments released by trypsin at higher temperatures.

A G Plaut, T B Tomasi.   

Abstract

Immunoglobulin M (IgM, 19S macroglobulin) is a high molecular weight antibody molecule currently thought to be composed of five identical 7S subunits linked by disulfide bonds, perhaps in a cyclic conformation. Reported molecular weights of IgM vary from 8 x 10(5) to 10(6). Proteolytic cleavage of this molecule under standard conditions with several enzymes results in the formation of ten antigen-binding (Fab) fragments per mole, each Fab having a molecular weight of 40,000. The remainder of the molecule, designated Fc by analogy with the structure of immunoglobulin G (IgG), is highly susceptible to further enzyme cleavage and breaks down to dialyzable peptides. However, under carefully controlled conditions, an intact Fc-like fragment in low yield can be isolated from short-term papain digests of IgM at 37 degrees C. Availability of the Fc portion of the molecule is important not only for structural studies but because it may determine certain important biological properties of the molecule such as complement fixation and placental permeability. We here report that trypsin cleavage of IgM at temperatures exceeding 50 degrees C results in the production of excellent yields of an intact Fc fragment, whereas no detectable Fc fragment is produced by trypsin cleavage at 37 degrees C. Fab fragments are obtained under both temperature conditions, and an Fab dimer has been identified in high temperature digests. This unusual difference in the products of enzyme digestion with temperature is unexplained but may be related to steric changes induced in the IgM molecule by heat. Fc fragment isolated from high temperature digests contains two-thirds of the carbohydrate of the intact molecule, and has a molecular weight of 342,000. The molecular weight falls to 67,300 after treatment with disulfide reducing agents, thus supporting the concept of a pentameric structure for IgM.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4984234      PMCID: PMC282904          DOI: 10.1073/pnas.65.2.318

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  8 in total

1.  EQUILIBRIUM ULTRACENTRIFUGATION OF DILUTE SOLUTIONS.

Authors:  D A YPHANTIS
Journal:  Biochemistry       Date:  1964-03       Impact factor: 3.162

2.  CHARACTERIZATION OF A HUMAN MACROGLOBULIN. I. THE MOLECULAR WEIGHT OF ITS SUBUNIT.

Authors:  F MILLER; H METZGER
Journal:  J Biol Chem       Date:  1965-08       Impact factor: 5.157

3.  The preparation and enzymatic hydrolysis of reduced and S-carboxymethylated proteins.

Authors:  A M CRESTFIELD; S MOORE; W H STEIN
Journal:  J Biol Chem       Date:  1963-02       Impact factor: 5.157

4.  Papain fragmentation of the subunits of human macroglobulin.

Authors:  K Onoue; T Kishimoto; Y Yamamura
Journal:  J Immunol       Date:  1967-02       Impact factor: 5.422

5.  Characterization of a human macroglobulin. 3. The products of tryptic digestion.

Authors:  F Miller; H Metzger
Journal:  J Biol Chem       Date:  1966-04-25       Impact factor: 5.157

6.  Studies on the chymotrypsin C and papain fragments of human immunoglobulin M.

Authors:  J P Chen; M Reichlin; T B Tomasi
Journal:  Biochemistry       Date:  1969-06       Impact factor: 3.162

7.  Characterization of a human macroglobulin. II. Distribution of the disulfide bonds.

Authors:  F Miller; H Metzger
Journal:  J Biol Chem       Date:  1965-12       Impact factor: 5.157

8.  Papain digestion fragments of human IgM globulins.

Authors:  C Mihaesco; M Seligmann
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

  8 in total
  37 in total

1.  Cross-idiotypic antigens among monoclonal immunoglobulin M from patients with Waldenström's macroglobulinemia and polyneuropathy.

Authors:  K Dellagi; J C Brouet; F Danon
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

2.  A comparative analysis of the C1-binding ability of fragments derived from complement-fixing and noncomplement-fixing IgM proteins.

Authors:  M M Hurst; J E Volanakis; R M Stroud; J C Bennett
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

3.  A sulfhydryl-rich IgM protein with multiple serological specificities.

Authors:  G Merlini; O Zettervall; A Forsgren; M Galliano; A A Lindberg; S B Svenson; F Pavesi; I Turesson
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

4.  Characterization of the receptor for IgM present on human B lymphocytes.

Authors:  G F Burns; J C Cawley; C R Barker
Journal:  Immunology       Date:  1979-03       Impact factor: 7.397

5.  Receptors for IgM on murine lymphoid cells.

Authors:  V Santana
Journal:  Immunology       Date:  1977-02       Impact factor: 7.397

6.  Phagocytic peripheral blood monocytes from rabbits and humans express membrane receptors specific for IgM molecules: evidence that incubation with neuraminidase exposes cryptic IgM (Fc) receptors.

Authors:  D G Haegert
Journal:  Clin Exp Immunol       Date:  1979-03       Impact factor: 4.330

7.  Human monoclonal IgM with autoantibody activity against two gangliosides (GM1 and GD1b) in a patient with motor neuron syndrome.

Authors:  M O Jauberteau; N Gualde; J L Preud'Homme; M Rigaud; R Gil; J M Vallat; N Baumann
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

8.  The importance of quaternary structure in the expression of the C1-binding site of IgM.

Authors:  M O Bubb; J D Conradie
Journal:  Immunology       Date:  1976-12       Impact factor: 7.397

9.  Amino acid sequence of the Fv region of a human monoclonal IgM (protein WEA) with antibody activity against 3,4-pyruvylated galactose in Klebsiella polysaccharides K30 and K33.

Authors:  F Goñi; B Frangione
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

10.  Identity of the elusive IgM Fc receptor (FcmuR) in humans.

Authors:  Hiromi Kubagawa; Satoshi Oka; Yoshiki Kubagawa; Ikuko Torii; Eiji Takayama; Dong-Won Kang; G Larry Gartland; Luigi F Bertoli; Hiromi Mori; Hiroyuki Takatsu; Toshio Kitamura; Hiroshi Ohno; Ji-Yang Wang
Journal:  J Exp Med       Date:  2009-10-26       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.